nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—ulcerative colitis	0.64	1	CpDpCtD
Naratriptan—MAOA—Nicotine—ulcerative colitis	0.183	1	CbGbCtD
Naratriptan—Eletriptan—PTGS1—ulcerative colitis	0.000839	0.479	CrCbGaD
Naratriptan—Sumatriptan—ABCB1—ulcerative colitis	0.000504	0.288	CrCbGaD
Naratriptan—Eletriptan—ABCB1—ulcerative colitis	0.000408	0.233	CrCbGaD
Naratriptan—Headache—Budesonide—ulcerative colitis	0.000118	0.000789	CcSEcCtD
Naratriptan—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000117	0.000785	CcSEcCtD
Naratriptan—Arrhythmia—Dexamethasone—ulcerative colitis	0.000117	0.000783	CcSEcCtD
Naratriptan—Arrhythmia—Betamethasone—ulcerative colitis	0.000117	0.000783	CcSEcCtD
Naratriptan—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000116	0.00078	CcSEcCtD
Naratriptan—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000116	0.000778	CcSEcCtD
Naratriptan—Bradycardia—Prednisone—ulcerative colitis	0.000116	0.000777	CcSEcCtD
Naratriptan—Alopecia—Betamethasone—ulcerative colitis	0.000115	0.000774	CcSEcCtD
Naratriptan—Alopecia—Dexamethasone—ulcerative colitis	0.000115	0.000774	CcSEcCtD
Naratriptan—Convulsion—Hydrocortisone—ulcerative colitis	0.000115	0.000774	CcSEcCtD
Naratriptan—Diarrhoea—Azathioprine—ulcerative colitis	0.000115	0.00077	CcSEcCtD
Naratriptan—Discomfort—Prednisolone—ulcerative colitis	0.000115	0.000769	CcSEcCtD
Naratriptan—Haemoglobin—Prednisone—ulcerative colitis	0.000114	0.000767	CcSEcCtD
Naratriptan—Haemorrhage—Prednisone—ulcerative colitis	0.000114	0.000763	CcSEcCtD
Naratriptan—Erythema—Dexamethasone—ulcerative colitis	0.000114	0.000763	CcSEcCtD
Naratriptan—Erythema—Betamethasone—ulcerative colitis	0.000114	0.000763	CcSEcCtD
Naratriptan—Myalgia—Hydrocortisone—ulcerative colitis	0.000113	0.00076	CcSEcCtD
Naratriptan—Hallucination—Prednisone—ulcerative colitis	0.000113	0.000759	CcSEcCtD
Naratriptan—Malaise—Triamcinolone—ulcerative colitis	0.000113	0.000758	CcSEcCtD
Naratriptan—Anxiety—Hydrocortisone—ulcerative colitis	0.000113	0.000757	CcSEcCtD
Naratriptan—Malaise—Methylprednisolone—ulcerative colitis	0.000113	0.000756	CcSEcCtD
Naratriptan—Vertigo—Triamcinolone—ulcerative colitis	0.000113	0.000755	CcSEcCtD
Naratriptan—Hypersensitivity—Mesalazine—ulcerative colitis	0.000112	0.000755	CcSEcCtD
Naratriptan—Syncope—Triamcinolone—ulcerative colitis	0.000112	0.000754	CcSEcCtD
Naratriptan—Vertigo—Methylprednisolone—ulcerative colitis	0.000112	0.000754	CcSEcCtD
Naratriptan—Syncope—Methylprednisolone—ulcerative colitis	0.000112	0.000752	CcSEcCtD
Naratriptan—Discomfort—Hydrocortisone—ulcerative colitis	0.000112	0.000751	CcSEcCtD
Naratriptan—Nausea—Budesonide—ulcerative colitis	0.000112	0.000748	CcSEcCtD
Naratriptan—Oedema—Prednisolone—ulcerative colitis	0.000111	0.000746	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000111	0.000746	CcSEcCtD
Naratriptan—Dizziness—Azathioprine—ulcerative colitis	0.000111	0.000744	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—ulcerative colitis	0.00011	0.000739	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.00011	0.000737	CcSEcCtD
Naratriptan—Asthenia—Mesalazine—ulcerative colitis	0.00011	0.000735	CcSEcCtD
Naratriptan—Shock—Prednisolone—ulcerative colitis	0.000109	0.000734	CcSEcCtD
Naratriptan—Cough—Triamcinolone—ulcerative colitis	0.000109	0.000734	CcSEcCtD
Naratriptan—Oedema—Hydrocortisone—ulcerative colitis	0.000109	0.000729	CcSEcCtD
Naratriptan—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000109	0.000729	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—ulcerative colitis	0.000109	0.000728	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—ulcerative colitis	0.000108	0.000727	CcSEcCtD
Naratriptan—Pruritus—Mesalazine—ulcerative colitis	0.000108	0.000725	CcSEcCtD
Naratriptan—Infection—Hydrocortisone—ulcerative colitis	0.000108	0.000724	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000107	0.000721	CcSEcCtD
Naratriptan—Shock—Hydrocortisone—ulcerative colitis	0.000107	0.000717	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—ulcerative colitis	0.000107	0.000716	CcSEcCtD
Naratriptan—Vomiting—Azathioprine—ulcerative colitis	0.000107	0.000715	CcSEcCtD
Naratriptan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000106	0.000715	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—ulcerative colitis	0.000106	0.000714	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—ulcerative colitis	0.000106	0.000714	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—ulcerative colitis	0.000106	0.000712	CcSEcCtD
Naratriptan—Rash—Azathioprine—ulcerative colitis	0.000106	0.000709	CcSEcCtD
Naratriptan—Dermatitis—Azathioprine—ulcerative colitis	0.000106	0.000709	CcSEcCtD
Naratriptan—Skin disorder—Hydrocortisone—ulcerative colitis	0.000105	0.000708	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000105	0.000708	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000105	0.000708	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—ulcerative colitis	0.000105	0.000707	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—ulcerative colitis	0.000105	0.000706	CcSEcCtD
Naratriptan—Headache—Azathioprine—ulcerative colitis	0.000105	0.000705	CcSEcCtD
Naratriptan—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000105	0.000704	CcSEcCtD
Naratriptan—Diarrhoea—Mesalazine—ulcerative colitis	0.000104	0.000701	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—ulcerative colitis	0.000104	0.0007	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—ulcerative colitis	0.000103	0.000692	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—ulcerative colitis	0.000103	0.00069	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—ulcerative colitis	0.000103	0.000689	CcSEcCtD
Naratriptan—Malaise—Betamethasone—ulcerative colitis	0.000103	0.000688	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—ulcerative colitis	0.000103	0.000688	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000102	0.000686	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—ulcerative colitis	0.000102	0.000686	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—ulcerative colitis	0.000102	0.000685	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—ulcerative colitis	0.000102	0.000685	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000102	0.000685	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—ulcerative colitis	0.000102	0.000684	CcSEcCtD
Naratriptan—Syncope—Betamethasone—ulcerative colitis	0.000102	0.000684	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—ulcerative colitis	0.000102	0.000682	CcSEcCtD
Naratriptan—Infection—Triamcinolone—ulcerative colitis	0.000102	0.000682	CcSEcCtD
Naratriptan—Hypotension—Hydrocortisone—ulcerative colitis	0.000101	0.000681	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—ulcerative colitis	0.000101	0.00068	CcSEcCtD
Naratriptan—Dizziness—Mesalazine—ulcerative colitis	0.000101	0.000678	CcSEcCtD
Naratriptan—Shock—Triamcinolone—ulcerative colitis	0.000101	0.000675	CcSEcCtD
Naratriptan—Alopecia—Prednisone—ulcerative colitis	0.0001	0.000674	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—ulcerative colitis	0.0001	0.000673	CcSEcCtD
Naratriptan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.0001	0.000671	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—ulcerative colitis	9.99e-05	0.00067	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—ulcerative colitis	9.99e-05	0.00067	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—ulcerative colitis	9.98e-05	0.00067	CcSEcCtD
Naratriptan—Nausea—Azathioprine—ulcerative colitis	9.96e-05	0.000668	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—ulcerative colitis	9.91e-05	0.000665	CcSEcCtD
Naratriptan—Erythema—Prednisone—ulcerative colitis	9.9e-05	0.000664	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	9.89e-05	0.000664	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—ulcerative colitis	9.88e-05	0.000663	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—ulcerative colitis	9.86e-05	0.000662	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—ulcerative colitis	9.85e-05	0.000661	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—ulcerative colitis	9.85e-05	0.000661	CcSEcCtD
Naratriptan—Paraesthesia—Hydrocortisone—ulcerative colitis	9.75e-05	0.000654	CcSEcCtD
Naratriptan—Vomiting—Mesalazine—ulcerative colitis	9.71e-05	0.000651	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—ulcerative colitis	9.68e-05	0.000649	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—ulcerative colitis	9.68e-05	0.000649	CcSEcCtD
Naratriptan—Anxiety—Betamethasone—ulcerative colitis	9.64e-05	0.000647	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—ulcerative colitis	9.64e-05	0.000647	CcSEcCtD
Naratriptan—Rash—Mesalazine—ulcerative colitis	9.63e-05	0.000646	CcSEcCtD
Naratriptan—Dermatitis—Mesalazine—ulcerative colitis	9.62e-05	0.000645	CcSEcCtD
Naratriptan—Headache—Mesalazine—ulcerative colitis	9.57e-05	0.000642	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—ulcerative colitis	9.56e-05	0.000642	CcSEcCtD
Naratriptan—Discomfort—Betamethasone—ulcerative colitis	9.56e-05	0.000642	CcSEcCtD
Naratriptan—Hypotension—Methylprednisolone—ulcerative colitis	9.53e-05	0.00064	CcSEcCtD
Naratriptan—Pain—Prednisolone—ulcerative colitis	9.51e-05	0.000638	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.37e-05	0.000629	CcSEcCtD
Naratriptan—Fatigue—Hydrocortisone—ulcerative colitis	9.36e-05	0.000628	CcSEcCtD
Naratriptan—Vision blurred—Prednisone—ulcerative colitis	9.33e-05	0.000626	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.31e-05	0.000625	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9.29e-05	0.000624	CcSEcCtD
Naratriptan—Pain—Hydrocortisone—ulcerative colitis	9.29e-05	0.000623	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—ulcerative colitis	9.28e-05	0.000623	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—ulcerative colitis	9.28e-05	0.000623	CcSEcCtD
Naratriptan—Oedema—Betamethasone—ulcerative colitis	9.28e-05	0.000623	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—ulcerative colitis	9.28e-05	0.000623	CcSEcCtD
Naratriptan—Infection—Dexamethasone—ulcerative colitis	9.22e-05	0.000618	CcSEcCtD
Naratriptan—Infection—Betamethasone—ulcerative colitis	9.22e-05	0.000618	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisone—ulcerative colitis	9.18e-05	0.000616	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—ulcerative colitis	9.18e-05	0.000616	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisolone—ulcerative colitis	9.16e-05	0.000615	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—ulcerative colitis	9.16e-05	0.000615	CcSEcCtD
Naratriptan—Anaemia—Prednisone—ulcerative colitis	9.15e-05	0.000614	CcSEcCtD
Naratriptan—Shock—Dexamethasone—ulcerative colitis	9.13e-05	0.000612	CcSEcCtD
Naratriptan—Shock—Betamethasone—ulcerative colitis	9.13e-05	0.000612	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—ulcerative colitis	9.12e-05	0.000612	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—ulcerative colitis	9.1e-05	0.00061	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—ulcerative colitis	9.1e-05	0.00061	CcSEcCtD
Naratriptan—Agitation—Prednisone—ulcerative colitis	9.1e-05	0.00061	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—ulcerative colitis	9.08e-05	0.00061	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—ulcerative colitis	9.08e-05	0.00061	CcSEcCtD
Naratriptan—Nausea—Mesalazine—ulcerative colitis	9.07e-05	0.000609	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—ulcerative colitis	8.97e-05	0.000602	CcSEcCtD
Naratriptan—Hyperhidrosis—Betamethasone—ulcerative colitis	8.97e-05	0.000602	CcSEcCtD
Naratriptan—Feeling abnormal—Hydrocortisone—ulcerative colitis	8.95e-05	0.0006	CcSEcCtD
Naratriptan—Malaise—Prednisone—ulcerative colitis	8.93e-05	0.000599	CcSEcCtD
Naratriptan—Vertigo—Prednisone—ulcerative colitis	8.89e-05	0.000597	CcSEcCtD
Naratriptan—Syncope—Prednisone—ulcerative colitis	8.88e-05	0.000596	CcSEcCtD
Naratriptan—Urticaria—Prednisolone—ulcerative colitis	8.83e-05	0.000593	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—ulcerative colitis	8.81e-05	0.000592	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—ulcerative colitis	8.8e-05	0.00059	CcSEcCtD
Naratriptan—Pain—Triamcinolone—ulcerative colitis	8.74e-05	0.000587	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—ulcerative colitis	8.7e-05	0.000584	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—ulcerative colitis	8.67e-05	0.000582	CcSEcCtD
Naratriptan—Hypotension—Dexamethasone—ulcerative colitis	8.67e-05	0.000582	CcSEcCtD
Naratriptan—Urticaria—Hydrocortisone—ulcerative colitis	8.63e-05	0.000579	CcSEcCtD
Naratriptan—Body temperature increased—Hydrocortisone—ulcerative colitis	8.58e-05	0.000576	CcSEcCtD
Naratriptan—Convulsion—Prednisone—ulcerative colitis	8.58e-05	0.000576	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.45e-05	0.000567	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.45e-05	0.000567	CcSEcCtD
Naratriptan—Myalgia—Prednisone—ulcerative colitis	8.43e-05	0.000566	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—ulcerative colitis	8.43e-05	0.000566	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—ulcerative colitis	8.43e-05	0.000565	CcSEcCtD
Naratriptan—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.41e-05	0.000564	CcSEcCtD
Naratriptan—Anxiety—Prednisone—ulcerative colitis	8.4e-05	0.000564	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—ulcerative colitis	8.33e-05	0.000559	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—ulcerative colitis	8.33e-05	0.000559	CcSEcCtD
Naratriptan—Discomfort—Prednisone—ulcerative colitis	8.33e-05	0.000559	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisolone—ulcerative colitis	8.19e-05	0.00055	CcSEcCtD
Naratriptan—Urticaria—Triamcinolone—ulcerative colitis	8.12e-05	0.000545	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—ulcerative colitis	8.1e-05	0.000544	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—ulcerative colitis	8.08e-05	0.000542	CcSEcCtD
Naratriptan—Oedema—Prednisone—ulcerative colitis	8.08e-05	0.000542	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—ulcerative colitis	8.08e-05	0.000542	CcSEcCtD
Naratriptan—Infection—Prednisone—ulcerative colitis	8.03e-05	0.000539	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.01e-05	0.000537	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.01e-05	0.000537	CcSEcCtD
Naratriptan—Hypersensitivity—Hydrocortisone—ulcerative colitis	8e-05	0.000537	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—ulcerative colitis	8e-05	0.000537	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—ulcerative colitis	8e-05	0.000537	CcSEcCtD
Naratriptan—Shock—Prednisone—ulcerative colitis	7.95e-05	0.000533	CcSEcCtD
Naratriptan—Pain—Dexamethasone—ulcerative colitis	7.93e-05	0.000532	CcSEcCtD
Naratriptan—Pain—Betamethasone—ulcerative colitis	7.93e-05	0.000532	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—ulcerative colitis	7.92e-05	0.000532	CcSEcCtD
Naratriptan—Skin disorder—Prednisone—ulcerative colitis	7.85e-05	0.000527	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—GNA12—ulcerative colitis	7.85e-05	0.00303	CbGpPWpGaD
Naratriptan—Hyperhidrosis—Prednisone—ulcerative colitis	7.81e-05	0.000524	CcSEcCtD
Naratriptan—MAOA—Neuronal System—CALM3—ulcerative colitis	7.8e-05	0.00302	CbGpPWpGaD
Naratriptan—Asthenia—Hydrocortisone—ulcerative colitis	7.79e-05	0.000523	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	7.75e-05	0.003	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCR6—ulcerative colitis	7.75e-05	0.00299	CbGpPWpGaD
Naratriptan—Pruritus—Hydrocortisone—ulcerative colitis	7.68e-05	0.000516	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—ulcerative colitis	7.64e-05	0.000513	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—ulcerative colitis	7.64e-05	0.000513	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—CCL20—ulcerative colitis	7.58e-05	0.00293	CbGpPWpGaD
Naratriptan—Hypersensitivity—Triamcinolone—ulcerative colitis	7.53e-05	0.000505	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.52e-05	0.000504	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CXCR2—ulcerative colitis	7.44e-05	0.00287	CbGpPWpGaD
Naratriptan—Diarrhoea—Hydrocortisone—ulcerative colitis	7.43e-05	0.000499	CcSEcCtD
Naratriptan—HTR1D—G alpha (i) signalling events—ADCY5—ulcerative colitis	7.4e-05	0.00286	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—ADCY5—ulcerative colitis	7.39e-05	0.00286	CbGpPWpGaD
Naratriptan—Urticaria—Dexamethasone—ulcerative colitis	7.37e-05	0.000495	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—ulcerative colitis	7.37e-05	0.000495	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.36e-05	0.000494	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—ulcerative colitis	7.35e-05	0.000493	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—ulcerative colitis	7.34e-05	0.000492	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—ulcerative colitis	7.33e-05	0.000492	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—ulcerative colitis	7.33e-05	0.000492	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—ulcerative colitis	7.32e-05	0.000491	CcSEcCtD
Naratriptan—Paraesthesia—Prednisone—ulcerative colitis	7.25e-05	0.000487	CcSEcCtD
Naratriptan—HTR1B—G alpha (i) signalling events—ADCY5—ulcerative colitis	7.25e-05	0.0028	CbGpPWpGaD
Naratriptan—Pruritus—Triamcinolone—ulcerative colitis	7.23e-05	0.000485	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—ulcerative colitis	7.22e-05	0.000484	CcSEcCtD
Naratriptan—Dizziness—Hydrocortisone—ulcerative colitis	7.18e-05	0.000482	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—GNA12—ulcerative colitis	7.12e-05	0.00275	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL20—ulcerative colitis	7.04e-05	0.00272	CbGpPWpGaD
Naratriptan—Rash—Prednisolone—ulcerative colitis	7.01e-05	0.00047	CcSEcCtD
Naratriptan—Dermatitis—Prednisolone—ulcerative colitis	7e-05	0.00047	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CCR6—ulcerative colitis	6.99e-05	0.0027	CbGpPWpGaD
Naratriptan—Diarrhoea—Methylprednisolone—ulcerative colitis	6.98e-05	0.000468	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—PTGER4—ulcerative colitis	6.97e-05	0.00269	CbGpPWpGaD
Naratriptan—Fatigue—Prednisone—ulcerative colitis	6.97e-05	0.000467	CcSEcCtD
Naratriptan—Headache—Prednisolone—ulcerative colitis	6.96e-05	0.000467	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	6.93e-05	0.00268	CbGpPWpGaD
Naratriptan—Constipation—Prednisone—ulcerative colitis	6.91e-05	0.000464	CcSEcCtD
Naratriptan—Vomiting—Hydrocortisone—ulcerative colitis	6.9e-05	0.000463	CcSEcCtD
Naratriptan—Rash—Hydrocortisone—ulcerative colitis	6.85e-05	0.000459	CcSEcCtD
Naratriptan—Dermatitis—Hydrocortisone—ulcerative colitis	6.84e-05	0.000459	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	6.82e-05	0.00264	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—PTGER4—ulcerative colitis	6.82e-05	0.00264	CbGpPWpGaD
Naratriptan—Headache—Hydrocortisone—ulcerative colitis	6.8e-05	0.000456	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	6.79e-05	0.00262	CbGpPWpGaD
Naratriptan—Dizziness—Triamcinolone—ulcerative colitis	6.76e-05	0.000454	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—CXCR2—ulcerative colitis	6.75e-05	0.00261	CbGpPWpGaD
Naratriptan—Dizziness—Methylprednisolone—ulcerative colitis	6.75e-05	0.000453	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisone—ulcerative colitis	6.66e-05	0.000447	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—ulcerative colitis	6.66e-05	0.000447	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—ulcerative colitis	6.66e-05	0.000447	CcSEcCtD
Naratriptan—Nausea—Prednisolone—ulcerative colitis	6.6e-05	0.000443	CcSEcCtD
Naratriptan—HTR1F—G alpha (i) signalling events—CXCL8—ulcerative colitis	6.59e-05	0.00255	CbGpPWpGaD
Naratriptan—Pruritus—Dexamethasone—ulcerative colitis	6.56e-05	0.00044	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—ulcerative colitis	6.56e-05	0.00044	CcSEcCtD
Naratriptan—Vomiting—Triamcinolone—ulcerative colitis	6.5e-05	0.000436	CcSEcCtD
Naratriptan—Vomiting—Methylprednisolone—ulcerative colitis	6.49e-05	0.000435	CcSEcCtD
Naratriptan—Nausea—Hydrocortisone—ulcerative colitis	6.45e-05	0.000433	CcSEcCtD
Naratriptan—Rash—Triamcinolone—ulcerative colitis	6.45e-05	0.000433	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—ulcerative colitis	6.44e-05	0.000432	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—ulcerative colitis	6.43e-05	0.000432	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—ulcerative colitis	6.43e-05	0.000431	CcSEcCtD
Naratriptan—Urticaria—Prednisone—ulcerative colitis	6.42e-05	0.000431	CcSEcCtD
Naratriptan—Headache—Triamcinolone—ulcerative colitis	6.41e-05	0.00043	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—ulcerative colitis	6.39e-05	0.000429	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—ulcerative colitis	6.39e-05	0.000429	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—GHRL—ulcerative colitis	6.38e-05	0.00247	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCR6—ulcerative colitis	6.35e-05	0.00245	CbGpPWpGaD
Naratriptan—Diarrhoea—Dexamethasone—ulcerative colitis	6.35e-05	0.000426	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—ulcerative colitis	6.35e-05	0.000426	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—CXCR2—ulcerative colitis	6.28e-05	0.00243	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	6.25e-05	0.00241	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—GHRL—ulcerative colitis	6.25e-05	0.00241	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SEL1L—ulcerative colitis	6.19e-05	0.00239	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PTGER4—ulcerative colitis	6.16e-05	0.00238	CbGpPWpGaD
Naratriptan—Dizziness—Dexamethasone—ulcerative colitis	6.13e-05	0.000412	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—ulcerative colitis	6.13e-05	0.000412	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—CXCR1—ulcerative colitis	6.08e-05	0.00235	CbGpPWpGaD
Naratriptan—Nausea—Triamcinolone—ulcerative colitis	6.07e-05	0.000408	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—ulcerative colitis	6.06e-05	0.000407	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	6.04e-05	0.00233	CbGpPWpGaD
Naratriptan—Hypersensitivity—Prednisone—ulcerative colitis	5.95e-05	0.000399	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—CXCR1—ulcerative colitis	5.95e-05	0.0023	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCR6—ulcerative colitis	5.9e-05	0.00228	CbGpPWpGaD
Naratriptan—Vomiting—Betamethasone—ulcerative colitis	5.9e-05	0.000396	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—ulcerative colitis	5.9e-05	0.000396	CcSEcCtD
Naratriptan—Rash—Betamethasone—ulcerative colitis	5.85e-05	0.000393	CcSEcCtD
Naratriptan—Rash—Dexamethasone—ulcerative colitis	5.85e-05	0.000393	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—ulcerative colitis	5.84e-05	0.000392	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—ulcerative colitis	5.84e-05	0.000392	CcSEcCtD
Naratriptan—Headache—Dexamethasone—ulcerative colitis	5.81e-05	0.00039	CcSEcCtD
Naratriptan—Headache—Betamethasone—ulcerative colitis	5.81e-05	0.00039	CcSEcCtD
Naratriptan—Asthenia—Prednisone—ulcerative colitis	5.8e-05	0.000389	CcSEcCtD
Naratriptan—Pruritus—Prednisone—ulcerative colitis	5.72e-05	0.000384	CcSEcCtD
Naratriptan—MAOA—Neuronal System—ADCY5—ulcerative colitis	5.66e-05	0.00219	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—GHRL—ulcerative colitis	5.64e-05	0.00218	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PTGER4—ulcerative colitis	5.59e-05	0.00216	CbGpPWpGaD
Naratriptan—Diarrhoea—Prednisone—ulcerative colitis	5.53e-05	0.000371	CcSEcCtD
Naratriptan—HTR1A—G alpha (i) signalling events—ADCY5—ulcerative colitis	5.52e-05	0.00213	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCR1—ulcerative colitis	5.52e-05	0.00213	CbGpPWpGaD
Naratriptan—Nausea—Dexamethasone—ulcerative colitis	5.51e-05	0.00037	CcSEcCtD
Naratriptan—Nausea—Betamethasone—ulcerative colitis	5.51e-05	0.00037	CcSEcCtD
Naratriptan—HTR1B—Signaling by GPCR—CXCR1—ulcerative colitis	5.4e-05	0.00209	CbGpPWpGaD
Naratriptan—Dizziness—Prednisone—ulcerative colitis	5.34e-05	0.000358	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—CCL20—ulcerative colitis	5.34e-05	0.00206	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—ADRB2—ulcerative colitis	5.28e-05	0.00204	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.24e-05	0.00202	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CHP1—ulcerative colitis	5.23e-05	0.00202	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCL20—ulcerative colitis	5.22e-05	0.00202	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PTGER4—ulcerative colitis	5.2e-05	0.00201	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	5.17e-05	0.002	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—ADRB2—ulcerative colitis	5.17e-05	0.002	CbGpPWpGaD
Naratriptan—Vomiting—Prednisone—ulcerative colitis	5.14e-05	0.000345	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	5.13e-05	0.00198	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—GHRL—ulcerative colitis	5.12e-05	0.00198	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCR1—ulcerative colitis	5.1e-05	0.00197	CbGpPWpGaD
Naratriptan—Rash—Prednisone—ulcerative colitis	5.09e-05	0.000342	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—ulcerative colitis	5.09e-05	0.000342	CcSEcCtD
Naratriptan—Headache—Prednisone—ulcerative colitis	5.06e-05	0.00034	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—GNA12—ulcerative colitis	5.02e-05	0.00194	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CALM3—ulcerative colitis	4.96e-05	0.00192	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	4.92e-05	0.0019	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—GNA12—ulcerative colitis	4.91e-05	0.0019	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL20—ulcerative colitis	4.85e-05	0.00187	CbGpPWpGaD
Naratriptan—Nausea—Prednisone—ulcerative colitis	4.8e-05	0.000322	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—GHRL—ulcerative colitis	4.76e-05	0.00184	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCR2—ulcerative colitis	4.76e-05	0.00184	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL20—ulcerative colitis	4.74e-05	0.00183	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—ADRB2—ulcerative colitis	4.67e-05	0.0018	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCR2—ulcerative colitis	4.66e-05	0.0018	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	4.59e-05	0.00177	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—GNA12—ulcerative colitis	4.56e-05	0.00176	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCR1—ulcerative colitis	4.53e-05	0.00175	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DLD—ulcerative colitis	4.51e-05	0.00174	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL20—ulcerative colitis	4.48e-05	0.00173	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CCR6—ulcerative colitis	4.47e-05	0.00173	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GNA12—ulcerative colitis	4.46e-05	0.00172	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CCR6—ulcerative colitis	4.38e-05	0.00169	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	4.36e-05	0.00169	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCR2—ulcerative colitis	4.32e-05	0.00167	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADRB2—ulcerative colitis	4.24e-05	0.00164	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCR2—ulcerative colitis	4.23e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—CXCL8—ulcerative colitis	4.21e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GNA12—ulcerative colitis	4.21e-05	0.00163	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	4.18e-05	0.00162	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—CXCL8—ulcerative colitis	4.12e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCR1—ulcerative colitis	4.12e-05	0.00159	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCR6—ulcerative colitis	4.06e-05	0.00157	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCR2—ulcerative colitis	3.99e-05	0.00154	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—CXCL8—ulcerative colitis	3.99e-05	0.00154	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCL20—ulcerative colitis	3.98e-05	0.00154	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCR6—ulcerative colitis	3.98e-05	0.00154	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—ADCY5—ulcerative colitis	3.96e-05	0.00153	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SEL1L—ulcerative colitis	3.96e-05	0.00153	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—ADRB2—ulcerative colitis	3.94e-05	0.00152	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTGER4—ulcerative colitis	3.94e-05	0.00152	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	3.9e-05	0.00151	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SEL1L—ulcerative colitis	3.88e-05	0.0015	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTGER4—ulcerative colitis	3.85e-05	0.00149	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCR6—ulcerative colitis	3.75e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GNA12—ulcerative colitis	3.74e-05	0.00145	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL20—ulcerative colitis	3.61e-05	0.0014	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—GHRL—ulcerative colitis	3.6e-05	0.00139	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADCY5—ulcerative colitis	3.6e-05	0.00139	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTGER4—ulcerative colitis	3.58e-05	0.00138	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3.57e-05	0.00138	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAML2—ulcerative colitis	3.56e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.55e-05	0.00137	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—GHRL—ulcerative colitis	3.53e-05	0.00136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTGER4—ulcerative colitis	3.5e-05	0.00135	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GNA12—ulcerative colitis	3.4e-05	0.00131	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.35e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CCR6—ulcerative colitis	3.34e-05	0.00129	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTGER4—ulcerative colitis	3.3e-05	0.00128	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.28e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—GHRL—ulcerative colitis	3.27e-05	0.00127	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCR1—ulcerative colitis	3.26e-05	0.00126	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCR2—ulcerative colitis	3.22e-05	0.00125	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—GHRL—ulcerative colitis	3.2e-05	0.00124	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCR1—ulcerative colitis	3.19e-05	0.00123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CALM3—ulcerative colitis	3.17e-05	0.00123	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.14e-05	0.00121	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CALM3—ulcerative colitis	3.1e-05	0.0012	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3.03e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCR6—ulcerative colitis	3.03e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—GHRL—ulcerative colitis	3.02e-05	0.00117	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADRB2—ulcerative colitis	2.98e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SEL1L—ulcerative colitis	2.95e-05	0.00114	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.94e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALM3—ulcerative colitis	2.93e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADRB2—ulcerative colitis	2.92e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RIPK2—ulcerative colitis	2.88e-05	0.00111	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.88e-05	0.00111	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL20—ulcerative colitis	2.86e-05	0.00111	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL20—ulcerative colitis	2.8e-05	0.00108	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADRB2—ulcerative colitis	2.71e-05	0.00105	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GNA12—ulcerative colitis	2.69e-05	0.00104	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—GHRL—ulcerative colitis	2.69e-05	0.00104	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTGER4—ulcerative colitis	2.67e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADRB2—ulcerative colitis	2.65e-05	0.00103	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GNA12—ulcerative colitis	2.64e-05	0.00102	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCR2—ulcerative colitis	2.55e-05	0.000986	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CXCL8—ulcerative colitis	2.55e-05	0.000986	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADCY5—ulcerative colitis	2.53e-05	0.000979	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADRB2—ulcerative colitis	2.5e-05	0.000967	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCR2—ulcerative colitis	2.5e-05	0.000966	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.5e-05	0.000965	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CXCL8—ulcerative colitis	2.5e-05	0.000965	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADCY5—ulcerative colitis	2.48e-05	0.000958	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—JAK2—ulcerative colitis	2.47e-05	0.000954	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.45e-05	0.000947	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—GHRL—ulcerative colitis	2.44e-05	0.000944	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCR1—ulcerative colitis	2.43e-05	0.00094	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCR6—ulcerative colitis	2.4e-05	0.000927	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALM3—ulcerative colitis	2.36e-05	0.000914	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCR6—ulcerative colitis	2.35e-05	0.000908	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADCY5—ulcerative colitis	2.3e-05	0.000889	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAML2—ulcerative colitis	2.27e-05	0.000879	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CXCL8—ulcerative colitis	2.25e-05	0.000871	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADCY5—ulcerative colitis	2.25e-05	0.00087	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—JAK2—ulcerative colitis	2.24e-05	0.000867	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAML2—ulcerative colitis	2.23e-05	0.000861	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADRB2—ulcerative colitis	2.23e-05	0.00086	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS1—ulcerative colitis	2.18e-05	0.000844	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL2—ulcerative colitis	2.15e-05	0.000832	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL20—ulcerative colitis	2.14e-05	0.000825	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADCY5—ulcerative colitis	2.12e-05	0.000821	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTGER4—ulcerative colitis	2.11e-05	0.000816	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTGER4—ulcerative colitis	2.07e-05	0.000799	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CXCL8—ulcerative colitis	2.05e-05	0.000791	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADRB2—ulcerative colitis	2.02e-05	0.000781	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNA12—ulcerative colitis	2.01e-05	0.000776	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CALM3—ulcerative colitis	1.97e-05	0.00076	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL2—ulcerative colitis	1.96e-05	0.000756	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GHRL—ulcerative colitis	1.93e-05	0.000747	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCR2—ulcerative colitis	1.9e-05	0.000736	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CXCL8—ulcerative colitis	1.9e-05	0.000735	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GHRL—ulcerative colitis	1.89e-05	0.000732	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.89e-05	0.00073	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALM3—ulcerative colitis	1.87e-05	0.000724	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RIPK2—ulcerative colitis	1.84e-05	0.000713	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALM3—ulcerative colitis	1.83e-05	0.000709	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RIPK2—ulcerative colitis	1.81e-05	0.000698	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCR6—ulcerative colitis	1.79e-05	0.000692	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.72e-05	0.000663	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAML2—ulcerative colitis	1.7e-05	0.000656	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADRB2—ulcerative colitis	1.6e-05	0.000619	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—JAK2—ulcerative colitis	1.58e-05	0.00061	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTGER4—ulcerative colitis	1.58e-05	0.000609	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADRB2—ulcerative colitis	1.57e-05	0.000606	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—JAK2—ulcerative colitis	1.55e-05	0.000597	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ABCB1—ulcerative colitis	1.53e-05	0.000591	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GHRL—ulcerative colitis	1.44e-05	0.000557	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—ulcerative colitis	1.44e-05	0.000557	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—JAK2—ulcerative colitis	1.43e-05	0.000554	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ADCY5—ulcerative colitis	1.43e-05	0.000551	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—ulcerative colitis	1.41e-05	0.000545	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—JAK2—ulcerative colitis	1.4e-05	0.000543	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALM3—ulcerative colitis	1.4e-05	0.00054	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—ulcerative colitis	1.38e-05	0.000532	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RIPK2—ulcerative colitis	1.38e-05	0.000532	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADCY5—ulcerative colitis	1.36e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—ulcerative colitis	1.35e-05	0.000521	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADCY5—ulcerative colitis	1.33e-05	0.000514	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—JAK2—ulcerative colitis	1.32e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—ulcerative colitis	1.31e-05	0.000506	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RELA—ulcerative colitis	1.28e-05	0.000496	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—ulcerative colitis	1.28e-05	0.000495	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—ulcerative colitis	1.25e-05	0.000483	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—ulcerative colitis	1.22e-05	0.000473	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—ulcerative colitis	1.21e-05	0.000467	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB2—ulcerative colitis	1.19e-05	0.000461	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.18e-05	0.000455	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—ulcerative colitis	1.16e-05	0.000446	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—ulcerative colitis	1.15e-05	0.000444	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—ulcerative colitis	1.09e-05	0.000423	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFKB1—ulcerative colitis	1.08e-05	0.000418	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.07e-05	0.000415	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	1.07e-05	0.000413	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—ulcerative colitis	1.06e-05	0.000411	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	1.03e-05	0.000397	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	1.01e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	9.76e-06	0.000377	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—ulcerative colitis	9.72e-06	0.000376	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—ulcerative colitis	9.56e-06	0.00037	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	9.33e-06	0.000361	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—ulcerative colitis	9.01e-06	0.000348	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	8.47e-06	0.000327	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—ulcerative colitis	8.36e-06	0.000323	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	8.29e-06	0.000321	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RELA—ulcerative colitis	8.2e-06	0.000317	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RELA—ulcerative colitis	8.03e-06	0.00031	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	7.73e-06	0.000299	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	7.57e-06	0.000293	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—ulcerative colitis	7.42e-06	0.000287	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—ulcerative colitis	7.39e-06	0.000286	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	7.35e-06	0.000284	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—ulcerative colitis	7.23e-06	0.00028	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	7.2e-06	0.000278	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	6.99e-06	0.00027	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	6.92e-06	0.000267	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	6.85e-06	0.000265	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—ulcerative colitis	6.79e-06	0.000262	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	6.77e-06	0.000262	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	6.32e-06	0.000244	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	6.22e-06	0.00024	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RELA—ulcerative colitis	6.12e-06	0.000236	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	6.09e-06	0.000235	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	5.77e-06	0.000223	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	5.76e-06	0.000223	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	5.64e-06	0.000218	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—ulcerative colitis	5.51e-06	0.000213	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	5.48e-06	0.000212	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	5.22e-06	0.000202	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	5.16e-06	0.000199	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—ulcerative colitis	4.74e-06	0.000183	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—ulcerative colitis	4.64e-06	0.00018	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	4.64e-06	0.000179	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—ulcerative colitis	4.34e-06	0.000168	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	4.3e-06	0.000166	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—ulcerative colitis	4.25e-06	0.000164	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—ulcerative colitis	3.54e-06	0.000137	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—ulcerative colitis	3.24e-06	0.000125	CbGpPWpGaD
